Close
Close
Treatment Database
single stranded, chemically modified oligonucleotide that binds to and inhibits the function of micro RNA-21
Trade Name not avaiable
Orphan Indication Alport syndrome
USA Market Approval
USA Designation Date 17-07-2014
Sponsor Genzyme Corporation
55 Corporate Drive, Mail Stop: 55C-300
Bridgewater, New Jersey, 08807
More about Alport syndrome
Free Newsletter
Related Videos
by Abidemi Uruejoma
5,568 views